Abstract
Adenocarcinomas occur in distal esophagus and often involve esophagogastric junction. Radiotherapy plays a key role in treatment, often in combination with chemotherapy and surgery in multi-modalities management. For resectable esophageal primaries, neoadjuvant chemoradiotherapy plus surgery can downstage disease and improve outcome over surgery alone. For patients with unresectable primaries or medically unfit for surgery, definitive chemoradiotherapy was found to improve survival over radiotherapy alone. For patients who had residual disease or involved margins after primary surgery, adjuvant chemoradiotherapy in postoperative setting was shown to improve local control and survival. Palliative radiotherapy can also be used to relieve local symptoms like dysphagia or bleeding. Careful radiotherapy planning is required to ensure adequate dose to target volumes without overdose to normal organs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Siewert JR, Marcus F, Werner M et al (2000) Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg 232:353–361
Rice TW, Ishwaran H, Ferguson MK et al (2016) Cancer of the esophagus and esophagogastric junction: an eighth edition staging primer. J Thorac Oncol 12:36–42
Miller C (1962) Carcinoma of thoracic esophagus and cardia: a review of 405 cases. Br J Surg 49:507–522
Shapiro J, van Lanschot JJ, Hulshof MC et al (2015) Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for esophageal or junctional cancer (CROSS): long term results of a randomised controlled trial. Lancet Oncol 16:1090–1098
Tepper J, Krasna MJ, Niedzwiecki D et al (2008) Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 26:1086–1092
Walsh TN, Noonan N, Hollywood D et al (1996) A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335:462–467
Herskovic A, Martz K, al-Sarraf M et al (1992) Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326:1593–1598
Yu E, Dar R, Rodrigues GB et al (2004) Is extended volume external beam radiation therapy covering the anastomotic-site beneficial in post-esophagectomy high risk patients? Radiother Oncol 73:141–148
MacDonald JS, Smalley SR, Benedetti J et al (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastresophageal junction. N Engl J Med 345:725–730
Vuong T, Szego P, David M et al (2005) The safety and usefulness of high-dose-rate endoluminal brachytherapy as a boost in the treatment of patients with esophageal cancer with external beam radiation with or without chemotherapy. Int J Radiat Oncol Biol Phys 63:758–764
Rosenblatt E, Jones G, Sur RK et al (2010) Adding external beam to intra-luminal brachytherapy improves palliation in obstructive squamous cell esophageal cancer; a prospective multi-centre randomized trial of the International Atomic Energy Agency. Radiother Oncol 97:488–494
Kong FM, Ritter T, Quint DL et al (2011) Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs and brachial plexus. J Radiat Oncol Biol Phys 81:1442–1457
Yang GY, McClosky SA, Khushalani NI (2009) Principles of modern radiation techniques for esophageal and gastresophageal junction cancers. Gastrointest Cancer Res 3(Suppl 1):S6–S10
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Kwong, D.L.W., Lam, K.O. (2018). Radiotherapy for Esophageal Adenocarcinoma. In: Lam, A. (eds) Esophageal Adenocarcinoma. Methods in Molecular Biology, vol 1756. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7734-5_2
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7734-5_2
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7733-8
Online ISBN: 978-1-4939-7734-5
eBook Packages: Springer Protocols